nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Vincristine—muscle cancer	0.151	0.224	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.151	0.224	CbGbCtD
Lercanidipine—CYP3A5—Vincristine—muscle cancer	0.114	0.168	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—muscle cancer	0.104	0.154	CbGbCtD
Lercanidipine—CYP3A4—Vincristine—muscle cancer	0.0443	0.0655	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—muscle cancer	0.0435	0.0643	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—muscle cancer	0.0406	0.06	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—muscle cancer	0.0277	0.0409	CbGbCtD
Lercanidipine—Nervous system disorder—Vincristine—muscle cancer	0.000942	0.00291	CcSEcCtD
Lercanidipine—Thrombocytopenia—Vincristine—muscle cancer	0.00094	0.00291	CcSEcCtD
Lercanidipine—Photosensitivity—Doxorubicin—muscle cancer	0.000935	0.00289	CcSEcCtD
Lercanidipine—Decreased appetite—Dactinomycin—muscle cancer	0.000934	0.00289	CcSEcCtD
Lercanidipine—Dysgeusia—Etoposide—muscle cancer	0.000933	0.00288	CcSEcCtD
Lercanidipine—Hyperhidrosis—Vincristine—muscle cancer	0.000928	0.00287	CcSEcCtD
Lercanidipine—Fatigue—Dactinomycin—muscle cancer	0.000927	0.00286	CcSEcCtD
Lercanidipine—Muscle spasms—Etoposide—muscle cancer	0.000916	0.00283	CcSEcCtD
Lercanidipine—Anorexia—Vincristine—muscle cancer	0.000915	0.00283	CcSEcCtD
Lercanidipine—Hepatic failure—Doxorubicin—muscle cancer	0.000913	0.00282	CcSEcCtD
Lercanidipine—Hypotension—Vincristine—muscle cancer	0.000897	0.00277	CcSEcCtD
Lercanidipine—Feeling abnormal—Dactinomycin—muscle cancer	0.000886	0.00274	CcSEcCtD
Lercanidipine—Ill-defined disorder—Etoposide—muscle cancer	0.000884	0.00273	CcSEcCtD
Lercanidipine—Anaemia—Etoposide—muscle cancer	0.000881	0.00272	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000879	0.00272	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000875	0.0027	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00087	0.00269	CcSEcCtD
Lercanidipine—Insomnia—Vincristine—muscle cancer	0.000868	0.00268	CcSEcCtD
Lercanidipine—Paraesthesia—Vincristine—muscle cancer	0.000862	0.00267	CcSEcCtD
Lercanidipine—Malaise—Etoposide—muscle cancer	0.000859	0.00266	CcSEcCtD
Lercanidipine—Breast disorder—Methotrexate—muscle cancer	0.000857	0.00265	CcSEcCtD
Lercanidipine—Vertigo—Etoposide—muscle cancer	0.000856	0.00265	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000854	0.00264	CcSEcCtD
Lercanidipine—Abdominal pain—Dactinomycin—muscle cancer	0.00085	0.00263	CcSEcCtD
Lercanidipine—Body temperature increased—Dactinomycin—muscle cancer	0.00085	0.00263	CcSEcCtD
Lercanidipine—Cardiac failure—Doxorubicin—muscle cancer	0.000841	0.0026	CcSEcCtD
Lercanidipine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000841	0.0026	CcSEcCtD
Lercanidipine—Loss of consciousness—Etoposide—muscle cancer	0.000838	0.00259	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000838	0.00259	CcSEcCtD
Lercanidipine—Decreased appetite—Vincristine—muscle cancer	0.000835	0.00258	CcSEcCtD
Lercanidipine—Cough—Etoposide—muscle cancer	0.000832	0.00257	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000829	0.00256	CcSEcCtD
Lercanidipine—Fatigue—Vincristine—muscle cancer	0.000828	0.00256	CcSEcCtD
Lercanidipine—Hyponatraemia—Doxorubicin—muscle cancer	0.000824	0.00255	CcSEcCtD
Lercanidipine—Constipation—Vincristine—muscle cancer	0.000821	0.00254	CcSEcCtD
Lercanidipine—Asthma—Methotrexate—muscle cancer	0.000819	0.00253	CcSEcCtD
Lercanidipine—Chest pain—Etoposide—muscle cancer	0.000811	0.00251	CcSEcCtD
Lercanidipine—Migraine—Doxorubicin—muscle cancer	0.000808	0.0025	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000806	0.00249	CcSEcCtD
Lercanidipine—Pancreatitis—Methotrexate—muscle cancer	0.000803	0.00248	CcSEcCtD
Lercanidipine—Discomfort—Etoposide—muscle cancer	0.000802	0.00248	CcSEcCtD
Lercanidipine—Face oedema—Doxorubicin—muscle cancer	0.000792	0.00245	CcSEcCtD
Lercanidipine—Hypersensitivity—Dactinomycin—muscle cancer	0.000792	0.00245	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Vincristine—muscle cancer	0.000785	0.00243	CcSEcCtD
Lercanidipine—Confusional state—Etoposide—muscle cancer	0.000784	0.00242	CcSEcCtD
Lercanidipine—Pancytopenia—Methotrexate—muscle cancer	0.000778	0.0024	CcSEcCtD
Lercanidipine—Asthenia—Dactinomycin—muscle cancer	0.000771	0.00238	CcSEcCtD
Lercanidipine—Blood creatinine increased—Doxorubicin—muscle cancer	0.000769	0.00238	CcSEcCtD
Lercanidipine—Neutropenia—Methotrexate—muscle cancer	0.000766	0.00237	CcSEcCtD
Lercanidipine—Thrombocytopenia—Etoposide—muscle cancer	0.000762	0.00235	CcSEcCtD
Lercanidipine—Tachycardia—Etoposide—muscle cancer	0.000759	0.00235	CcSEcCtD
Lercanidipine—Body temperature increased—Vincristine—muscle cancer	0.000759	0.00235	CcSEcCtD
Lercanidipine—Abdominal pain—Vincristine—muscle cancer	0.000759	0.00235	CcSEcCtD
Lercanidipine—Skin disorder—Etoposide—muscle cancer	0.000756	0.00234	CcSEcCtD
Lercanidipine—Erectile dysfunction—Methotrexate—muscle cancer	0.000755	0.00233	CcSEcCtD
Lercanidipine—Hyperhidrosis—Etoposide—muscle cancer	0.000752	0.00232	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00075	0.00232	CcSEcCtD
Lercanidipine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00075	0.00232	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000748	0.00231	CcSEcCtD
Lercanidipine—Breast disorder—Doxorubicin—muscle cancer	0.000742	0.00229	CcSEcCtD
Lercanidipine—Anorexia—Etoposide—muscle cancer	0.000741	0.00229	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000739	0.00228	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000739	0.00228	CcSEcCtD
Lercanidipine—Diarrhoea—Dactinomycin—muscle cancer	0.000735	0.00227	CcSEcCtD
Lercanidipine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000734	0.00227	CcSEcCtD
Lercanidipine—Hypotension—Etoposide—muscle cancer	0.000727	0.00225	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000724	0.00224	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000724	0.00224	CcSEcCtD
Lercanidipine—Muscular weakness—Doxorubicin—muscle cancer	0.000724	0.00224	CcSEcCtD
Lercanidipine—Renal failure—Methotrexate—muscle cancer	0.000718	0.00222	CcSEcCtD
Lercanidipine—Stomatitis—Methotrexate—muscle cancer	0.000712	0.0022	CcSEcCtD
Lercanidipine—Asthma—Doxorubicin—muscle cancer	0.000709	0.00219	CcSEcCtD
Lercanidipine—Hypersensitivity—Vincristine—muscle cancer	0.000707	0.00219	CcSEcCtD
Lercanidipine—Paraesthesia—Etoposide—muscle cancer	0.000698	0.00216	CcSEcCtD
Lercanidipine—Pancreatitis—Doxorubicin—muscle cancer	0.000696	0.00215	CcSEcCtD
Lercanidipine—Dyspnoea—Etoposide—muscle cancer	0.000693	0.00214	CcSEcCtD
Lercanidipine—Somnolence—Etoposide—muscle cancer	0.000691	0.00214	CcSEcCtD
Lercanidipine—Angina pectoris—Doxorubicin—muscle cancer	0.000691	0.00214	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000691	0.00214	CcSEcCtD
Lercanidipine—Asthenia—Vincristine—muscle cancer	0.000689	0.00213	CcSEcCtD
Lercanidipine—Vomiting—Dactinomycin—muscle cancer	0.000683	0.00211	CcSEcCtD
Lercanidipine—Agranulocytosis—Methotrexate—muscle cancer	0.000682	0.00211	CcSEcCtD
Lercanidipine—Rash—Dactinomycin—muscle cancer	0.000678	0.00209	CcSEcCtD
Lercanidipine—Decreased appetite—Etoposide—muscle cancer	0.000676	0.00209	CcSEcCtD
Lercanidipine—Pancytopenia—Doxorubicin—muscle cancer	0.000674	0.00208	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000672	0.00208	CcSEcCtD
Lercanidipine—Fatigue—Etoposide—muscle cancer	0.000671	0.00207	CcSEcCtD
Lercanidipine—Constipation—Etoposide—muscle cancer	0.000665	0.00206	CcSEcCtD
Lercanidipine—Neutropenia—Doxorubicin—muscle cancer	0.000663	0.00205	CcSEcCtD
Lercanidipine—Diarrhoea—Vincristine—muscle cancer	0.000657	0.00203	CcSEcCtD
Lercanidipine—Hepatitis—Methotrexate—muscle cancer	0.000656	0.00203	CcSEcCtD
Lercanidipine—Pollakiuria—Doxorubicin—muscle cancer	0.000655	0.00203	CcSEcCtD
Lercanidipine—Urinary tract disorder—Methotrexate—muscle cancer	0.000648	0.002	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000648	0.002	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—muscle cancer	0.000643	0.00199	CcSEcCtD
Lercanidipine—Feeling abnormal—Etoposide—muscle cancer	0.000641	0.00198	CcSEcCtD
Lercanidipine—Nausea—Dactinomycin—muscle cancer	0.000638	0.00197	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Etoposide—muscle cancer	0.000636	0.00197	CcSEcCtD
Lercanidipine—Dizziness—Vincristine—muscle cancer	0.000635	0.00196	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000627	0.00194	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—muscle cancer	0.000622	0.00192	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—muscle cancer	0.00062	0.00192	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00062	0.00192	CcSEcCtD
Lercanidipine—Urticaria—Etoposide—muscle cancer	0.000618	0.00191	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—muscle cancer	0.000617	0.00191	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—muscle cancer	0.000617	0.00191	CcSEcCtD
Lercanidipine—Abdominal pain—Etoposide—muscle cancer	0.000615	0.0019	CcSEcCtD
Lercanidipine—Body temperature increased—Etoposide—muscle cancer	0.000615	0.0019	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—muscle cancer	0.000613	0.00189	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—muscle cancer	0.000611	0.00189	CcSEcCtD
Lercanidipine—Vomiting—Vincristine—muscle cancer	0.00061	0.00189	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—muscle cancer	0.000609	0.00188	CcSEcCtD
Lercanidipine—Rash—Vincristine—muscle cancer	0.000605	0.00187	CcSEcCtD
Lercanidipine—Dermatitis—Vincristine—muscle cancer	0.000605	0.00187	CcSEcCtD
Lercanidipine—Headache—Vincristine—muscle cancer	0.000602	0.00186	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000598	0.00185	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—muscle cancer	0.000595	0.00184	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—muscle cancer	0.000592	0.00183	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—muscle cancer	0.000591	0.00183	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—muscle cancer	0.00059	0.00182	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—muscle cancer	0.000579	0.00179	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—muscle cancer	0.000575	0.00178	CcSEcCtD
Lercanidipine—Hypersensitivity—Etoposide—muscle cancer	0.000573	0.00177	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—muscle cancer	0.000571	0.00176	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—muscle cancer	0.000571	0.00176	CcSEcCtD
Lercanidipine—Nausea—Vincristine—muscle cancer	0.00057	0.00176	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—muscle cancer	0.000569	0.00176	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—muscle cancer	0.000568	0.00176	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000561	0.00173	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—muscle cancer	0.000559	0.00173	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—muscle cancer	0.000559	0.00173	CcSEcCtD
Lercanidipine—Asthenia—Etoposide—muscle cancer	0.000558	0.00172	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000558	0.00172	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—muscle cancer	0.000557	0.00172	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—muscle cancer	0.00055	0.0017	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—muscle cancer	0.000538	0.00166	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—muscle cancer	0.000537	0.00166	CcSEcCtD
Lercanidipine—Diarrhoea—Etoposide—muscle cancer	0.000532	0.00164	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—muscle cancer	0.000531	0.00164	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—muscle cancer	0.00053	0.00164	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—muscle cancer	0.000529	0.00164	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—muscle cancer	0.000528	0.00163	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—muscle cancer	0.000527	0.00163	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—muscle cancer	0.000527	0.00163	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—muscle cancer	0.000515	0.00159	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—muscle cancer	0.000515	0.00159	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—muscle cancer	0.000514	0.00159	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—muscle cancer	0.000513	0.00159	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—muscle cancer	0.000513	0.00159	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000512	0.00158	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—muscle cancer	0.000502	0.00155	CcSEcCtD
Lercanidipine—Cough—Methotrexate—muscle cancer	0.000498	0.00154	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—muscle cancer	0.000497	0.00154	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—muscle cancer	0.000495	0.00153	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—muscle cancer	0.000494	0.00153	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—muscle cancer	0.000494	0.00153	CcSEcCtD
Lercanidipine—Rash—Etoposide—muscle cancer	0.00049	0.00152	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—muscle cancer	0.00049	0.00151	CcSEcCtD
Lercanidipine—Headache—Etoposide—muscle cancer	0.000487	0.00151	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—muscle cancer	0.000486	0.0015	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—muscle cancer	0.000486	0.0015	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—muscle cancer	0.000486	0.0015	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—muscle cancer	0.000485	0.0015	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—muscle cancer	0.000484	0.0015	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000483	0.00149	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—muscle cancer	0.00048	0.00148	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—muscle cancer	0.00048	0.00148	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—muscle cancer	0.000475	0.00147	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—muscle cancer	0.00047	0.00145	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—muscle cancer	0.000466	0.00144	CcSEcCtD
Lercanidipine—Nausea—Etoposide—muscle cancer	0.000462	0.00143	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000459	0.00142	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—muscle cancer	0.000457	0.00141	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—muscle cancer	0.000457	0.00141	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—muscle cancer	0.000456	0.00141	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—muscle cancer	0.000453	0.0014	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—muscle cancer	0.00045	0.00139	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—muscle cancer	0.000446	0.00138	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—muscle cancer	0.000444	0.00137	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—muscle cancer	0.000444	0.00137	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—muscle cancer	0.000443	0.00137	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—muscle cancer	0.000437	0.00135	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—muscle cancer	0.000435	0.00135	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—muscle cancer	0.000434	0.00134	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—muscle cancer	0.000431	0.00133	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000424	0.00131	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—muscle cancer	0.000421	0.0013	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—muscle cancer	0.000421	0.0013	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—muscle cancer	0.000421	0.0013	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—muscle cancer	0.000421	0.0013	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—muscle cancer	0.000419	0.0013	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—muscle cancer	0.000418	0.00129	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000418	0.00129	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—muscle cancer	0.000416	0.00129	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—muscle cancer	0.000415	0.00128	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—muscle cancer	0.000414	0.00128	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—muscle cancer	0.000412	0.00127	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—muscle cancer	0.00041	0.00127	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—muscle cancer	0.000407	0.00126	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—muscle cancer	0.000405	0.00125	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000402	0.00124	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—muscle cancer	0.000402	0.00124	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—muscle cancer	0.000397	0.00123	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—muscle cancer	0.000396	0.00122	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000395	0.00122	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—muscle cancer	0.000394	0.00122	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—muscle cancer	0.000392	0.00121	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00039	0.00121	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—muscle cancer	0.000385	0.00119	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—muscle cancer	0.000384	0.00119	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000381	0.00118	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—muscle cancer	0.000377	0.00117	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—muscle cancer	0.00037	0.00114	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—muscle cancer	0.000368	0.00114	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—muscle cancer	0.000368	0.00114	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000368	0.00114	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—muscle cancer	0.000365	0.00113	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—muscle cancer	0.000362	0.00112	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—muscle cancer	0.00036	0.00111	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—muscle cancer	0.000359	0.00111	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—muscle cancer	0.000355	0.0011	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—muscle cancer	0.000351	0.00108	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000348	0.00108	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—muscle cancer	0.000348	0.00108	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—muscle cancer	0.000345	0.00107	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—muscle cancer	0.000343	0.00106	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—muscle cancer	0.000334	0.00103	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—muscle cancer	0.000332	0.00103	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00033	0.00102	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—muscle cancer	0.00033	0.00102	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—muscle cancer	0.00032	0.000991	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—muscle cancer	0.000319	0.000986	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—muscle cancer	0.000319	0.000986	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—muscle cancer	0.000319	0.000985	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—muscle cancer	0.000308	0.000952	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—muscle cancer	0.000297	0.000919	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—muscle cancer	0.000296	0.000916	CcSEcCtD
Lercanidipine—Rash—Methotrexate—muscle cancer	0.000294	0.000908	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—muscle cancer	0.000293	0.000907	CcSEcCtD
Lercanidipine—Headache—Methotrexate—muscle cancer	0.000292	0.000902	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—muscle cancer	0.000289	0.000895	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—muscle cancer	0.000285	0.000882	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—muscle cancer	0.000277	0.000855	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—muscle cancer	0.000276	0.000853	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—muscle cancer	0.000267	0.000825	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—muscle cancer	0.000257	0.000793	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—muscle cancer	0.000254	0.000786	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—muscle cancer	0.000254	0.000786	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—muscle cancer	0.000253	0.000781	CcSEcCtD
Lercanidipine—Nausea—Doxorubicin—muscle cancer	0.00024	0.000741	CcSEcCtD
